...
首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Insufficient histone-3 lysine-9 deacetylation in human oocytes matured in vitro is associated with aberrant meiosis
【24h】

Insufficient histone-3 lysine-9 deacetylation in human oocytes matured in vitro is associated with aberrant meiosis

机译:体外成熟的人卵母细胞中组蛋白3赖氨酸9脱乙酰不足与异常减数分裂有关

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To characterize histone acetylation during meiosis in human oocytes matured in vitro or in vivo. Design: Experimental study. Setting: University reproductive medical center. Patient(s): Patients undergoing routine intracytoplasmic sperm injection (ICSI) cycles. Intervention(s): Immature and mature oocytes were collected from patients undergoing intracytoplasmic sperm injection. Main Outcome Measure(s): Immunohistochemical assessment of the levels of acetylated lysine-9 of histone-3 (H3K9) and lysine-12 of histone-4 (H4K12) combined with spindle and chromosome configurations in in vitro- and in vivo-matured human oocytes. Transcript levels of histone deacetylases (HDACs) 1 and 2 were measured by single-cell quantitative polymerase chain reaction. Result(s): Acetylation of H3K9 and H4K12 decreased during human oocyte maturation. Residual H3K9 acetylation was found in 37.7% of oocytes matured in vitro, compared with 11.8% in oocytes matured in vivo. Abnormal metaphase spindle was more frequent in oocytes with residual histone acetylation than without (51.6% vs. 25.4%, respectively). Treatment with the HDAC inhibitor trichostatin A increased the incidence of an abnormal metaphase but had no adverse effect on maturation efficiency. Furthermore, expression of HDAC1 transcripts was significantly lower in oocytes matured in vitro versus in vivo. Conclusion(s): Reduced HDAC1 expression and insufficient histone deacetylation are associated with metaphase defects in human oocytes matured in vitro.
机译:目的:表征体外或体内成熟的人卵母细胞减数分裂过程中的组蛋白乙酰化。设计:实验研究。地点:大学生殖医学中心。患者:接受常规胞浆内精子注射(ICSI)周期的患者。干预措施:从接受胞浆内精子注射的患者中收集未成熟和成熟的卵母细胞。主要观察指标:在体外和体内成熟的组蛋白3的乙酰化赖氨酸9(H3K9)和组蛋白4的赖氨酸12(H4K12)的免疫组织化学评估中,结合纺锤体和染色体构型人卵母细胞。通过单细胞定量聚合酶链反应测量组蛋白脱乙酰基酶(HDACs)1和2的转录水平。结果:在人类卵母细胞成熟过程中,H3K9和H4K12的乙酰化程度降低。在体外成熟的卵母细胞中发现37.7%的残留H3K9乙酰化,而在体内成熟的卵母细胞中则为11.8%。残留组蛋白乙酰化的卵母细胞异常中期纺锤体发生频率更高(分别为51.6%和25.4%)。用HDAC抑制剂曲古抑菌素A进行治疗可增加异常中期的发生率,但对成熟效率无不利影响。此外,与体内相比,在体外成熟的卵母细胞中,HDAC1转录物的表达明显降低。结论:HDAC1表达降低和组蛋白去乙酰化不足与体外成熟人卵母细胞的中期缺陷有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号